Press releases

15 December 2015
Result of AGM

15 December 2015
CHK1 Clinical Trial Applications

13 November 2015
Notice of AGM

26 October 2015
Final Results

15 September 2015
US and European Patent Grants for Aurora+FLT3

23 July 2015
CHK1 Research Update

First description of the CHK1 clinical development candidate published in peer-reviewed journal: New ‘chemotherapy booster’ could treat lung and pancreatic cancer

17 June 2015
FUNDING AWARD FROM INNOVATE UK

Award of up to £140,000 to investigate the potential of TYK2 inhibitors to treat adolescent leukaemia

28 May 2015
Placing

21 May 2015
Sareum Launches New Website

12 May 2015
Sareum to Present at BioTrinity 2015

07 May 2015
Early Conclusion of Equity Swap Agreement

16 March 2015
Change of Adviser

25 February 2015
Research & Co-Development Collaborations Update

25 February 2015
Half-yearly Report

20 January 2015
Further US Patent Grant for Sareum’s Kinase Inhibitors

31 December 2012
Total Voting Rights

12 December 2012
Result of AGM

12 December 2012
Annual General Meeting Statement

05 December 2012
Issue of Equity

14 November 2012
Notice of AGM

13 November 2012
Availability of Report and Accounts

06 November 2012
Statement re Share Price Movement

03 October 2012
Final Results

10 September 2012
Financing

07 August 2012
Statement re Share Price Movement

19 July 2012
Trading Update

29 June 2012
Total Voting Rights

07 June 2012
Placing

06 June 2012
Placing

13 March 2012
Issue of Options & Transfer of Shares

27 February 2012
Research Update

27 February 2012
Half-Yearly Report

30 January 2012
Notice of Results